Cite
Veterans Affairs Cooperative Studies Program Study #553: Chemotherapy After Prostatectomy for High-risk Prostate Carcinoma: A Phase III Randomized Study.
MLA
Lin, Daniel W., et al. “Veterans Affairs Cooperative Studies Program Study #553: Chemotherapy After Prostatectomy for High-Risk Prostate Carcinoma: A Phase III Randomized Study.” European Urology, vol. 77, no. 5, May 2020, pp. 563–72. EBSCOhost, https://doi.org/10.1016/j.eururo.2019.12.020.
APA
Lin, D. W., Shih, M.-C., Aronson, W., Basler, J., Beer, T. M., Brophy, M., Cooperberg, M., Garzotto, M., Kelly, W. K., Lee, K., McGuire, V., Wang, Y., Lu, Y., Markle, V., Nseyo, U., Ringer, R., Savage, S. J., Sinnott, P., Uchio, E., … Montgomery, R. B. (2020). Veterans Affairs Cooperative Studies Program Study #553: Chemotherapy After Prostatectomy for High-risk Prostate Carcinoma: A Phase III Randomized Study. European Urology, 77(5), 563–572. https://doi.org/10.1016/j.eururo.2019.12.020
Chicago
Lin, Daniel W, Mei-Chiung Shih, William Aronson, Joseph Basler, Tomasz M Beer, Mary Brophy, Matthew Cooperberg, et al. 2020. “Veterans Affairs Cooperative Studies Program Study #553: Chemotherapy After Prostatectomy for High-Risk Prostate Carcinoma: A Phase III Randomized Study.” European Urology 77 (5): 563–72. doi:10.1016/j.eururo.2019.12.020.